Understanding Pay For Performance and DIR Impact to Pharmacy Reimbursement
|
|
- Sabina Daniels
- 6 years ago
- Views:
Transcription
1 Understanding Pay For and DIR Impact to Pharmacy Reimbursement
2 A Public Service Announcement brought to you by Melanie Maxwell, MHP Vice President RxSelect Pharmacy Services
3 Please Don t Shoot the Messenger PBMs PBMs
4 Why Plans/PBMs Embrace Pay for? Increased market pressure to control costs and increase profitability.
5 How Do Plans/PBMs Benefit From Pay for? Increased Beneficiary Enrollment Star Rated plans have certain marketing and enrollment advantages over lower rated plans. Members in a low rated plan can switch to a star rated plan at any time throughout the year, not just during open enrollment. CMS star ratings have been shown to influence Medicare beneficiaries choice of a plan. Increased Revenue MA PD Plans achieving star ratings of 4 ( above average ) or ( excellent ) receive quality bonus payments, which can potentially represent millions of dollars in revenue.
6
7
8
9
10
11
12 Let s Take A Look at Some P4P Contract Examples
13 Example A: Pay for Payment How the is d Diabetes PDC Target: 8% Pharmacy Percentile Ranking RASA PDC Target: 8% Pharmacy Percentile Ranking Cholesterol PDC Target: 83% Pharmacy Percentile Ranking 8.27% =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0% % =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0% % =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0%
14 Example A: Pay for Payment How the Dollars Work #of patients by Diabetes RASA Cholesterol Total Weighted Overall 200/2 = 9.6 Overall Payment Pharmacy Overall 9.6 Overall =>9 to 0 =>8 to <9 =>7 to < 8 =>6 to < 7 => to <6 =>4 to < =>3 to <4 =>2 to <3 => to <2 $.4 $3.79 $2.44 $.09 $9.74 $0.00 $0.00 $0.00 $0.00 $0.00 Payment Calculation $.4 Multiplied by Patient 2 Count Total Payment Available $,892.0 Less MTM Payments [$200.00] Payment Due Pharmacy $,692.0
15 Example B: Pay for Commercial and Medicaid Plans (Optional Plan Participation) Payment How the is d Diabetes PDC Congestive Heart Failure Non RASA Hypertension Respiratory PDC RASA PDC Coronary Artery Disease PDC Breast Cancer PDC Depression PDC Each is evaluated individually and then weighted by number of patients by pharmacy. Cholesterol PDC Osteoporosis PDC Behavioral Health PDC Pharmacy (Each ) Pharmacy Target Percentile Ranking Diabetes Congestive Heart Failure Non RASA Hypertension Respiratory RASA Coronary Artery Disease Breast Cancer Depression Cholesterol Osteoporosis Behavioral Health 8.7% 66.% 66.6% 7% 83.2% 40% 83.2%.7% 84.4% 78.4% 00% 8% 84% 70% 8% 86% 8% 83% 78% =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0%
16 Example B: Pay for Commercial and Medicaid Plans (Optional Plan Participation) Payment How the Dollars Work Perf. #of patients by Weighted Perf. Diabetes CHF Non RASA Respiratory RASA CAD Breast Cancer Depression Cholesterol Osteoporosis Behavioral Health Total Overall 260/3 = 7.46 Overall Payment Pharmacy Overall 7.46 Overall =>9 to 0 =>8 to <9 =>7 to < 8 =>6 to < 7 => to <6 =>4 to < =>3 to <4 =>2 to <3 => to <2 $.0 $0.4 $9.40 $8.3 $7.30 $0.00 $0.00 $0.00 $0.00 $0.00 Payment Calculation $9.40 Multiplied by Patient 3 Count Total Payment Available $3, Less MTM Payments [$200.00] Payment Due Pharmacy $3,37.00
17 Example C: Pay for Payments by Reduced DIR Fees A New Type of Network Program has been developed. It contains three components:. Payment scores for key adherence measures 2. DIR Fee Reduction individual pharmacy performance determines level of DIR assessed. 3. Re Credentialing and Attestation Requirement pharmacy must complete recredentialing requirements AND complete Medicare program attestations by end of year.
18 What is DIR?...Direct and Indirect Remuneration Paraphrased Definition from CMS 42 CFR Section any and all rebates, subsidies, or other price concessions from any source Including manufacturers, pharmacies, enrollees, or any other person or entity) that serve to decrease the costs incurred by the Part D sponsor (whether directly or indirectly) for the Part D drug. -includes price concessions from manufacturers received by subcontractors of Part D sponsors, such as PBM. May include risk-sharing arrangements, generic dispensing incentive payments made after the point-of-sale.
19 What is DIR?...Direct and Indirect Remuneration The Real Reason Plans (PBMs) like DIR When calculating a Plan s risk share with CMS: Higher percent of the DIR fee is used to reduce a Plan s administrative costs instead of being applied directly to drug cost.
20 Example C: Pay for Based DIR Fee Reduction How s are d Category ACE/ARB Statin Diabetes GAP Therapy (statin) CMR Completion Rate % High Risk Meds Formulary Compliance Weight 20% 20% 20% 2% % % % DIR Fee (% of IngCost Paid) 3.% 4 4.0% 3 4.% 2.0%.% NOTE: DIR Fees are deducted from 83 Remittance Advice. You do not see DIR fees on the adjudicated claim response.
21 Example C: Pay for Based DIR Fee Reduction How the Dollars Work Category Weight Pharmacy A Pharmacy B ACE/ARB Statin Diabetes GAP Therapy (statin) CMR Completion Rate % High Risk Meds Formulary Compliance 20% 20% 20% 2% % % % Weighted Average
22 Example C: Pay for Based DIR Fee Reduction How the Dollars Work Impact to Reimbursement Esomeprazole 40mg Pharmacy A Pharmacy B Ingredient Cost Paid $ $ Dispense Fee Paid $.00 $.00 Patient Copay $0.00 $0.00 Total Amount Paid $ $ DIR Fee $8.0 $2.6 Total Net Reimbursement $22.93 $ $4.60 variance on reimbursement due to performance
23 Example D: Pay for Payment How the Dollars Work Generic Dispense Rate Extended Day Dispense Rate High Risk Meds Pharmacy GDR Target Range Pharmacy EDS Target Range Pharmacy Target Goal 86.4% 87.9% 86% to 87.9% 84% to 8.9% 82% to 83.9% <82% % 8% % to 7.9% 3% to.9% 0% to 2.9% <0% % 7% 7.% to 9% 9.% to 3% 3.% to 7% 7.% 4 3 2
24 Example D: Pay for Payment How the Dollars Work Retro DIR Adjustment Lump Sum Adjustment on Remittance Advice #of patients by Average Calculation GDR 4 EDS 2 High Risk Meds 4 Overall 3.33 Overall Payment Pharmacy Overall 3.33 Average Pharmacy Range to to to to.9 DIR Fee $2.00 $2.0 $3.00 $3.0 $4.00 ment Period Month DIR Payable Q 206 (Jan Mar) June 206 Q2 206 (Apr Jun) Sept 206 Q3 206 (Jul Sep) Dec 206 Q4 206 (Oct Dec) March 207
25 If Only PBMs Were Paid for
26 If Only PBMs Were Paid for
27 THANK YOU!
DIR FEES: WHAT YOU NEED TO KNOW JULY 13, :00 10:00 AM
DIR FEES: WHAT YOU NEED TO KNOW JULY 13, 2017 9:00 10:00 AM ACPE UAN: 0107-9999-17-078-L04-P 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists: Upon completion of this CPE
More informationDIR fees are knocking down pharmacy profits
16 America s PHARMACIST November 2016 DIR fees are knocking down pharmacy profits by Bruce A. Semingson, Pharmacist In 2016, retail pharmacy will pay between $360 million and $2.16 billion in direct and
More informationDIR: Trends, Issues, and Impending Impacts
DIR: Trends, Issues, and Impending Impacts Lari Harding Vice President, Product Marketing Chris Smith, R.Ph Director, Pharmacy Business Intelligence 1 Disclosures Lari Harding is the Vice President, Product
More informationImplement a definition of negotiated price to include all pharmacy price concessions.
NCPA Analysis of Medicare Part D Pharmacy DIR Fee Reform Policy Proposal and Other Policies Impacting Community Pharmacies in the CMS Proposed Rule, Modernizing Part D and Medicare Advantage to Lower Drug
More informationThe Impact of Adherence Quality Measures on the US Healthcare Marketplace
The Impact of Adherence Quality Measures on the US Healthcare Marketplace Samuel Stolpe, PharmD Associate Director, Quality Initiatives Pharmacy Quality Alliance Pharmacy Quality Alliance (PQA) Established
More informationHow Medication Adherence and Outcomes Are Changing the Business Model
How Medication Adherence and Outcomes Are Changing the Business Model Laura Cranston Executive Director Todd Sega Manager, Payer Relations Lari Harding VP, Strategy & Growth Healthcare Network 3 Session
More informationSTAR RATINGS PBM PARTNERSHIP, MAXIMUM RESULTS. Michelle Juhanson, CHC, CHPC Director of Compliance and Quality PerformRx
STAR RATINGS PBM PARTNERSHIP, MAXIMUM RESULTS Michelle Juhanson, CHC, CHPC Director of Compliance and Quality PerformRx Agenda History & Timeline Quality Bonus Payment CMS Changes The PBM Role Best Practices
More informationHow you are being measured by health plans, PBMs and accreditation organizations. December 2013
How you are being measured by health plans, PBMs and accreditation organizations December 2013 1 The U.S. health care system is rapidly moving to valuebased purchasing or value-driven healthcare Value
More informationMedicare 2017 Part C & D Star Rating Technical Notes
Medicare 2017 Part C & D Star Rating Technical Notes Updated 09/26/2016 Document Change Log Previous Version Description of Change Revision Date - Final 2017 Part C & D Star Ratings Technical Notes, fall
More informationPay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion
Pay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion Panelists: Mark Conklin, Pharmacy Quality Solutions Alex Cruz, Healthfirst Crystal Lennartz, Health Mart Jesse McCullough,
More informationSurvey Analysis of January 2014 CMS Medicare Part D Proposed Rule
Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule Prepared for: Pharmaceutical Care Management Association Prepared by: Stephen J. Kaczmarek, FSA, MAAA Principal and Consulting Actuary
More informationPresented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President
Presented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President Disclosures Don Dietz is an employee of Pharmacy Healthcare Solu0ons, Inc. The conflict of interest was
More informationCMS Medicare Advantage 2018 Advance Notice Summary
CMS Medicare Advantage 2018 Advance Notice Summary KEY HIGHLIGHTS February 2017 Risk Adjustment Part C Coding Intensity Adjustment: 5.91% Part C Normalization Factor: 1.017 Adjusted Effective Growth Rate
More informationFact Sheet Part C and D Star Ratings
Fact Sheet - 2018 Part C and D Star Ratings Note: The information included in this Fact Sheet is based on the 2018 Star Ratings published on Medicare Plan Finder (MPF) on October 11, 2017. For details
More informationJanuary 16, Ms. Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Blvd. Baltimore, Maryland 21244
January 16, 2018 Ms. Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Blvd. Baltimore, Maryland 21244 Re: MAPRx Draft Comment Letter on Medicare Program; Contract Year 2019
More informationMedicare Advantage: Early Views and Trend Spotting: What We Know From Analyzing Public Data Files
Medicare Advantage: Early Views and Trend Spotting: What We Know From Analyzing Public Data Files By Marsha Gold, Sc.D. Senior Fellow Mathematica Policy Research Presentation to the Alliance for Health
More informationSummary of Benefits for Blue MedicareRx Standard SM (PDP), Blue MedicareRx Plus SM (PDP) and Blue MedicareRx Premier SM (PDP)
Summary of Benefits for Standard SM (PDP), Plus SM (PDP) and Premier SM (PDP) Available in Colorado A -approved Part D sponsor. Anthem Insurance Companies, Inc. (AICI) has contracted with the Centers for
More informationProvisions of the Medicare Modernization Act
Provisions of the Medicare Modernization Act Medicare Prescription Drug Modernization and Improvement Act of 2003 (MMA) Todd Whitney, FSA, MAAA Wakely Consulting Group Highlights of New Act New Rx Benefit
More informationMedicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014
Medicaid Prescribed Drug Program Spending Control Initiatives For the Quarter April 1, 2014 through June 30, 2014 Report to the Florida Legislature January 2015 Table of Contents Purpose of Report... 1
More informationMedicare Advantage Value-Based Insurance Design: Considerations and implications
White paper Medicare Advantage Value-Based Insurance Design: Considerations and implications Health plans and providers are slowly moving away from traditional provider payment systems to a more innovative
More informationI. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
More informationNational Conference of State Legislatures Impact of Medicare Modernization and New Accounting Rules on States as Employers and Plan Sponsors
December 8, 2004 National Conference of State Legislatures Impact of Medicare Modernization and New Accounting Rules on States as Employers and Plan Sponsors Derek N. Guyton, FSA, MAAA Chicago, Illinois
More informationUnderstanding Your Medicare Options. Medicare Made Clear
Understanding Your Medicare Options Medicare Made Clear 1. Eligibility 2. Coverage Options 3. Enrollment 4. Next Steps 5. Resources Agenda 2 ELIGIBILITY Medicare Made Clear ELIGIBILITY Original Medicare
More informationSecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals
SecurityBlue HMO Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality
More informationMEDICARE PLAN PAYMENT GROUP
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 MEDICARE PLAN PAYMENT GROUP Date: June 23, 2017 To: From: All Part
More informationLinking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance
Linking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance Medicare Rx Part D Compliance Conf. Monday, December 8, 2008 9:45 a.m. 10:45 a.m. Cynthia Tudor, PhD Director
More informationMEDICARE PLAN PAYMENT GROUP
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 MEDICARE PLAN PAYMENT GROUP Date: May 30, 2018 To: From: All Part D
More informationWorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal
WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond Kristin Begley, Pharm.D. Principal Presentation Overview The future of drug trend Prescription drug management levers: Contracting
More informationMedicaid Prescribed Drug Program. Spending Control Initiatives
Medicaid Prescribed Drug Program Spending Control Initiatives For Quarters Ended September 30, December 31, Table of Contents Purpose of Report... 1 Executive Summary... 2 Pharmacy Appropriations and Spending
More informationIntroduction to Medicare Parts C and D
Lippincott Law Firm PLLC Introduction to Medicare Parts C and D Elizabeth Lippincott, Esq. American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues March 20, 2013 Agenda Overview
More informationPart II: Medicare Part C and Part D
Part II: Medicare Part C and Part D Part II: Part C and Part D Part C (Medicare Advantage)... 1 Enhanced Payments to Plans for Certain Beneficiary Types... 1 Special Needs Plans: Enrollment of Medicare
More information2017 Number of Contracts. Weighted by Enrollment
Fact Sheet - 2019 Part C and D Star Ratings Note: The information included in this Fact Sheet is based on the 2019 Star Ratings published on Medicare Plan Finder (MPF) on October 10, 2018. For details
More informationSession 64PD, Risk-Sharing Arrangements in Medicare Advantage
Session 64PD, Risk-Sharing Arrangements in Medicare Advantage Presenters: Adam J. Barnhart, FSA, MAAA Hillary H. Millican, FSA, MAAA Simon J. Moody, FSA, MAAA SOA Antitrust Disclaimer SOA Presentation
More informationSpecial Report: Medicare Part D. A Research Resource with Insights into. Medicare Part D
Special Report: Medicare Part D 2006 A Research Resource with Insights into Medicare Part D SilverScript SM is an indirect wholly-owned subsidiary of Caremark that offers a nationally-approved Medicare
More informationPACE & Medicare Part D
PACE & Medicare Part D www.npaonline.org Shawn Bloom National PACE Association Shawnb@npaonline.org (703) 535-1518 PACE & Part D Session Objectives PACE Medication Regulations What Does Part D Cover What
More informationPart D Performance Audits - Formulary Administration
Part D Performance Audits - Formulary Administration February 13, 2012 Medicare Drug Benefit and C&D Data Group Centers for Medicare & Medicaid Services Judith Geisler, R.Ph., CHC Formulary Administration
More informationMedicAre: don t delay. apply for Medicare as soon as you become eligible. You ve earned it. Make the most of it.
2015 don t delay. apply for Medicare as soon as you become eligible. MedicAre: You ve earned it. Make the most of it. You can enroll in Medicare the three months before, during and the three months after
More informationSeeing Stars in Puerto Rico
Seeing Stars in Puerto Rico Stephen Wood Senior Vice President, Development Universal American March 6, 2014 1 What s in the Stars? 2014 Stars scores have improved na
More informationPharmacy Benefit Managers Overview
Pharmacy Benefit Managers Overview A Presentation to the House Health Innovation Subcommittee Mary Alice Nye, Ph.D. Health and Human Services Staff Director, OPPAGA December 6, 2017 Pharmacy Benefit Managers
More informationDisease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry
Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry Jeffrey A. Bourret, M.S., R.Ph., FASHP Senior Director, Managed Markets Healthcare Systems Marketing
More informationEligibility and Enrollment in the Medicare Prescription Drug Program
Eligibility and Enrollment in the Medicare Prescription Drug Program Danielle Moon, Centers for Medicare and Medicaid Services Linda A. Malek, Esq., Partner Moses & Singer LLP Medicare Prescription Drug
More information2019 Transition Policy
2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members
More informationLow Income Health Program Performance Dashboard CMSP
Low Income Health Program Performance Dashboard CMSP January 1, 2012 - December 31, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge to Reform
More informationBlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals
BlueRx PDP Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality Assurance
More informationLow Income Health Program Performance Dashboard Riverside
Low Income Health Program Performance Dashboard Riverside January 1, 2012 - December 31, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge
More informationsummary of benefits Blue Shield of California Medicare Rx Plan (PDP)
summary of benefits Blue Shield of California Medicare Rx Plan (PDP) An employer-sponsored Medicare Prescription Drug Plan for City and County of San Francisco retirees, spouses and eligible dependents
More informationReleased: February 19, Comments Due: March 4, 2016
SUMMARY AMCP Summary: Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter Released:
More informationLow Income Health Program Performance Dashboard Santa Cruz
Low Income Health Program Performance Dashboard Santa Cruz January 1, 2012 - December 31, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge
More informationSpecialty Pharmacy: A Key to Organizational Success in Population Health Management
Specialty Pharmacy: A Key to Organizational Success in Population Health Management Scott Knoer, MS, PharmD, FASHP Chief Pharmacy Officer, Cleveland Clinic Steve Rough, MS, RPh, FASHP Director of Pharmacy,
More informationSummary of Benefits. Aetna Medicare Rx Costco Plus Plan (PDP) S5810. California. January 1, 2010 to December 31, 2010
January 1, 2010 to December 31, 2010 Summary of Benefits Aetna Medicare Rx S5810 California S5810_D_PE_SB_90712 (08/2009) Visit us www.aetnamedicare.com 1 Summary of Benefits: Aetna Medicare Rx Section
More informationImpact of H.R. 1038/S. 413 on CMS Payments Under Part D
At the request of the (NCPA), Wakely Consulting Group, LLC (Wakely) has estimated the financial impact of companion House and Senate bills H.R. 1038/S. 413 ( Improving Transparency and Accuracy in Medicare
More informationLow Income Health Program Performance Dashboard San Diego
Low Income Health Program Performance Dashboard San Diego July 1, 2011 - December 31, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge to
More informationToday PBMs control the pharmacy benefits of more than 253 MILLION Americans.
The PBM Story Decades ago, insurance companies expanded their coverage to include prescription drugs. They turned to a new kind of company, a sort of middleman, to process prescription drug claims. For
More informationToday PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.
The PBM Story Decades ago, insurance companies expanded their coverage to include prescription drugs. They turned to a new kind of company, a sort of middleman, to process prescription drug claims. For
More informationLow Income Health Program Performance Dashboard Orange
Low Income Health Program Performance Dashboard Orange July 1, 2011 - September 30, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge to Reform
More informationSummary of CY2019 Proposed Medicare Advantage and Part D Policy & Technical Changes
Summary of CY2019 Proposed Medicare Advantage and Part D Policy & Technical Changes Overview Prepared by Wakely Consulting Group The Centers for Medicare and Medicaid Services ( CMS ) recently released
More informationBusiness & Financial Services December 2017
Business & Financial Services December 217 Completed Procurement Transactions by Month 2 4 175 15 125 1 75 5 2 1 Business Days to Complete 25 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 217 Procurement
More informationSummary of Benefits. January 1 December 31, 2011
Summary of Benefits January 1 December 31, 2011 Section 1: Introduction to the Summary of Benefits Report for Medco Medicare Prescription Plan (PDP) January 1, 2011 December 31, 2011 Thank you for your
More information2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:
2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),
More informationPREMIUM IMPACT OF REMOVING MANUFACTURER REBATES FROM THE MEDICARE PART D PROGRAM
PREMIUM IMPACT OF REMOVING MANUFACTURER REBATES FROM THE MEDICARE PART D PROGRAM July 6, 2018 RANDALL FITZPATRICK FSA, MAAA CHRIS CARLSON FSA, MAAA CONTENTS Executive Summary... 2 Data and Methodology...
More informationMedicare Updates. Illinois Department on Aging Senior Health Insurance Program (SHIP)
Medicare 2015 Updates Governor s Conference on Aging & Disability Session W2, Wednesday December 10, 2014 Illinois Department on Aging Senior Health Insurance Program (SHIP) 800-252-8966 Aging.SHIP@illinois.gov
More information2019 Benefits. Emeriti Retirement Health TIM LANE PRESIDENT AND CEO OF EMERITI HEAD OF TIAA HEALTH
Emeriti Retirement Health 2019 Benefits TIM LANE PRESIDENT AND CEO OF EMERITI HEAD OF TIAA HEALTH CHRISTINA FENDLEY VICE PRESIDENT FOR INSTITUTIONAL CLIENT RELATIONSHIPS EMERITI ANN MOSES SENIOR ACCOUNT
More informationAnnual Compliance Deadlines for Health Plans
Provided by Clark & Associates of Nevada, Inc. Annual Compliance Deadlines for Health Plans Employers that provide group health plan coverage to their employees are subject to numerous compliance requirements
More informationPart D: The New Medicare Prescription Drug Law Implications for Medicaid
Part D: The New Medicare Prescription Drug Law Implications for Medicaid Vernon K. Smith, Ph.D. HEALTH MANAGEMENT ASSOCIATES For State Coverage Initiatives National Meeting Washington, D.C. February 4,
More informationAmerican Health Lawyers Association Medicare Advantage and Part D: Plan Provider Relationships in Light of Recent CMS Enforcement Actions
American Health Lawyers Association Medicare Advantage and Part D: Plan Provider Relationships in Light of Recent CMS Enforcement Actions March 1, 2016 2:00-3:30 PM Emily A. Moseley Lippincott Law Firm,
More informationLow Income Health Program Performance Dashboard San Mateo
Low Income Health Program Performance Dashboard San Mateo July 1, 2011 - December 31, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge to
More informationACHIA Operations Report
Monthly Operations Report ACHIA Operations Report January 209 Levels of Service February 208 - January 209 Levels of Service Feb-8 Mar-8 Apr-8 May-8 Jun-8 Jul-8 Aug-8 Sep-8 Oct-8 Nov-8 Dec-8 Jan-9 Enrollment
More informationCommunity Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018
Title: and H2034 HMO-SNP 2018 Policy Identifier: PA - Pharmacy Effective Date: 20180101 Scope: Organization Wide Family Care PACE Partnership Waukesha Day Center HUD (Housing and Urban Development) Department:
More informationMEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C
MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C Coverage Statement This Policy is applicable to: Medco PDP, Beneficiaries, Enhanced PDPs, Client PDPs and Client MA-PDs, to the extent
More informationMEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers
MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Reporting Requirements: Audit Preparedness for PDPs and Manufacturers Polaris Management Partners 8:30 9:30am Concurrent Breakout Session AGENDA
More information2011 Summary of Benefits
2011 Summary of Benefits (PDP) and January 1, 2011 December 31, 2011 BlueCross BlueShield of South Carolina contracts with the federal government. Contract # s5953 (PDP) s5953_pdp2011sb cms approved 08312010
More informationMedicare Part D: Retiree Drug Subsidy
A D V I S O R Y S E R V I C E S Medicare Part D: Retiree Drug Subsidy Programs to Control Fraud, Waste, and Abuse September, 2006 K P M G L L P Overview Summary Medicare Part D Prescription Drug Program
More informationReleased: November 16, Comments Due: January 16, 2018
AMCP Summary: Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs,
More information2020 Medicare Advantage
www.wakely.com 2020 Medicare Advantage Summary of Advance Rate Notice Part 2 February 7, 2019 page i Table of Contents Executive Summary... 1 Attachment I: Preliminary Estimates of the National Per Capita
More informationPrescription Drug Rebates and Part D Drug Costs
Prescription Drug Rebates and Part D Drug Costs Analysis of historical Medicare Part D drug prices and manufacturer rebates Prepared for: America s Health Insurance Plans Prepared by: Nicholas J. Johnson,
More information2017 Medicare Advantage and Prescription Drug Overview. Module 2
2017 Medicare Advantage and Prescription Drug Overview Module 2 Medicare Advantage Section 1 Proprietary and Confidential Information of UPMC Health Plan Medicare Advantage Three types of Medicare Advantage
More informationHealthy Michigan Plan signing, September 2013
Healthy Michigan Plan signing, September 2013 Richard Hirth, Ph.D. Professor & Chair Department of Health Management & Policy National Significance of Michigan Medicaid Expansion Model for compromise as
More informationLow Income Health Program Performance Dashboard Tulare
Low Income Health Program Performance Dashboard Tulare March 1, 2013 - December 31, 2013 About the Low Income Health Program The Low Income Health Program (LIHP), authorized under the 2010 Bridge to Reform
More informationSummary of Benefits. Regence Medicare Script TM. Enhanced (PDP) Basic (PDP) Medicare Prescription Drug Plan for Utah
2013 Summary of Benefits Medicare Prescription Drug Plan for Utah Regence Medicare Script TM Enhanced (PDP) Regence Medicare Script TM Basic (PDP) Regence BlueCross BlueShield of Utah is an Independent
More information(PDP) 2014 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard)
(PDP) 2014 Summary of benefits for our prescription drug plans (Enhanced and Standard) Contract S5540, Plans 004 and 002 January 1, 2014 December 31, 2014 U5073c, 8/13 Y0079_6249 CMS Accepted 09112013
More information2010 Summary of Benefits S5601
P.O. Box 280200, Nashville, TN 37228 Contact SilverScript Insurance Company for more information about our plans NOTE: Please contact us if you have questions or concerns about our plans. representatives
More information2012 Medi-Pak Rx (PDP) Prescription Drug Plans. S5795_REV_RX_FF_KIT_10_11 CMS Approved This is an advertisement.
2012 Medi-Pak Rx (PDP) Prescription Drug Plans S5795_REV_RX_FF_KIT_10_11 CMS Approved 07222011 This is an advertisement. Rx AG BK Choose a Medi-Pak Rx (PDP) prescription drug Blue Shield for savings, convenience
More informationFarm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017
P.O. Box 266380 Weston, FL 33326 Farm Bureau Select Rx 2017 Summary of Benefits January 1, 2017 - December 31, 2017 Thank you for your interest in Farm Bureau Select Rx, Our plan is offered by Members
More information2017 Group Retiree Medicare Plans
2017 Group Retiree Medicare Plans Standard Health Maintenance Organization (HMO) Plans Empire BlueCross BlueShield is an HMO and PDP plan with a Medicare contract. Enrollment in Empire BlueCross BlueShield
More informationSupport and pass provider status legislation in the House and Senate (H.R. 592/S. 109).
ISSUES Preserve beneficiary access to pharmacy services provided to Medicaid, Medicare and commercially-insured patients as Congress continues to debate health care policy. Support and pass provider status
More informationYour 2017 Kaiser Permanente Guide to Medicare. Kaiser Permanente Senior Advantage (HMO) Kaiser Permanente Medicare Plus (Cost) Y0043_N accepted
Your 2017 Kaiser Permanente Guide to Medicare Kaiser Permanente Senior Advantage (HMO) Kaiser Permanente Medicare Plus (Cost) Y0043_N017184 accepted Gain knowledge and confidence in choosing the right
More informationAppendix. Year Total drug spending reaching catastrophic coverage, $
Appendix Exhibit A. Low-income Subsidy Copayments in 2006-2012 Year 2006 2007 2008 2009 2010 2011 2012 Total drug spending reaching catastrophic coverage, $ 5100 5451.25 5726.25 6153.75 6440 6447.5 6657.5
More informationUnderstanding Private- Sector Medicare
Understanding Private- Sector Medicare A primer for investors Updated June 27, 2013 This presentation is intended for informational purposes only to give the reader a basic understanding of the Medicare
More informationMedicare Modernization Act (MMA)
Medicare Modernization Act (MMA) Julian Whitekus SEAC Conference Charlotte, N.C. November 16 18, 2005 WHAT IS AT STAKE : Projected U.S. Retail Rx Drug Spending 2005 (Total = $223.5 billion) 2006 (Total
More informationMedicare Health & Drug Plan Quality and Performance Ratings 2012 Part C & Part D Technical Notes. First Plan Preview DRAFT
Medicare Health & Drug Plan Quality and Performance Ratings 2012 Part C & Part D Technical Notes First Plan Preview Updated 08/04/2011 Table of Contents INTRODUCTION... 1 DIFFERENCES BETWEEN THE 2011 PLAN
More informationSELF-FUNDED PPO HEALTH PLAN RATE REQUIREMENTS RETIREES JANUARY 1, 2017 DECEMBER 31, 2017 COUNTY OF ORANGE JUNE 2016
SELF-FUNDED PPO HEALTH PLAN RATE REQUIREMENTS RETIREES JANUARY 1, 2017 DECEMBER 31, 2017 COUNTY OF ORANGE JUNE 2016 Page 1 of 12 CONTENTS 1. Introduction...1 2. Rate Adjustment...2 3. Reserve Fund...4
More information2019 Transition Policy and Procedure
2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process
More informationAHLA. L. Medicare Advantage New Developments and Key Legal Issues. Anne W. Hance McDermott Will & Emery LLP Washington, DC
AHLA L. Medicare Advantage New Developments and Key Legal Issues Anne W. Hance McDermott Will & Emery LLP Washington, DC Institute on Medicare and Medicaid Payment Issues March 26-28, 2014 Recent Developments
More informationAll Medicare Advantage Products with Part D Benefits
SUBJECT: TYPE: DEPARTMENT: Transition Process For Medicare Part D Departmental Pharmacy Care Management EFFECTIVE: 1/2017 REVISED: APPLIES TO: All Medicare Advantage Products with Part D Benefits POLICY
More informationMedicare Part D Transition Policy CY 2018 HCSC Medicare Part D
Contract: H0107, H0927, H1666, H3251, H3822, H3979, H8133, H8634, H8554, S5715 Policy Name: Medicare Formulary Transition Purpose: This procedure describes the standard process Health Care Service Corporation
More informationAssessing the Medicare Advantage Star Ratings
July 2018 Healthcare Systems and Services Practice Assessing the Medicare Advantage Star Ratings Dan Jamieson, Monisha Machado-Pereira, Stephanie Carlton, and Cara Repasky 1 Assessing the Medicare Advantage
More informationPopulation Health and Wellness: 2 Stories from Cleveland Clinic. Elizabeth Sump Senior Director, Health Policy Cleveland Clinic
Population Health and Wellness: 2 Stories from Cleveland Clinic Elizabeth Sump Senior Director, Health Policy Cleveland Clinic 1 2 population health stories Cleveland Clinic Employee Health Plan Cleveland
More informationPolicy Evaluation: HB 2126 Oregon Health Plan Preferred Drug List Enforcement and Voluntary Mental Health Preferred Drug List
Drug Use Research & Management Program DHS Division of Medical Assistance Programs, 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Policy Evaluation: HB 2126 Oregon
More informationPrescription Medicines: Costs in Context. Updated August 2016
Prescription Medicines: Costs in Context Updated August 2016 Medicines are Transforming the Treatment OF DEVASTATING DISEASES HEPATITIS C The leading cause of liver transplants and the reason liver cancer
More informationVALUE-BASED PAYMENTS, STAR RATINGS AND THE LESSONS OF MEDICARE ADVANTAGE. A Presentation to the 11 th Annual Value-Based Payment and P4P Summit
VALUE-BASED PAYMENTS, STAR RATINGS AND THE LESSONS OF MEDICARE ADVANTAGE A Presentation to the 11 th Annual Value-Based Payment and P4P Summit JOHN GORMAN EXECUTIVE CHAIRMAN FEBRUARY 19, 2016 CUT TO THE
More information